{"schema_version":"secwatch.filing_event.v1","accession":"0001140361-26-035537","form_type":"8-K","ticker":"APGE","cik":"0001974640","company_name":"Apogee Therapeutics, Inc.","filed_at":"2026-09-03T12:53:40+00:00","discovered_at":"2026-09-03T12:55:00.300390+00:00","generated_at":"2026-09-03T12:55:22.662042+00:00","sec_items":["1.02","2.01","3.01","3.03","5.01","5.02","5.03","9.01"],"event_type":"m_and_a","sentiment":"neutral","materiality_score":1.0,"calibrated_materiality_score":1.0,"confidence":"high","headline":"Apogee completes $10.9B acquisition by AbbVie; shareholders get $135.11/share","bullets":["Merger completed Sept 3, 2026; each share converted to $135.11 cash, total equity value ~$10.9B.","Company to delist from Nasdaq; trading suspended Sept 4, 2026, Form 25 to be filed.","All directors resigned; new directors from Merger Sub appointed; execs stepped down.","Parachute payment agreements with named execs, capped at $12.5M aggregate for 280G gross-ups.","2023 Equity Incentive Plan and ESPP terminated effective at close."],"urls":{"canonical":"https://secwatch.observer/filing/0001140361-26-035537","json":"https://secwatch.observer/filing/0001140361-26-035537.json","markdown":"https://secwatch.observer/filing/0001140361-26-035537.md","text":"https://secwatch.observer/filing/0001140361-26-035537.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1974640/000114036126035537/0001140361-26-035537-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1974640/000114036126035537/ef20081397_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-09-03T12:55:22.662042+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"04bffa779a","claim":"Lisa Bollinger resigned as Director at Apogee Therapeutics, Inc..","evidence_excerpt":"all of the Company’s directors (Michael Henderson, M.D., Mark C. McKenna, Lisa Bollinger, M.D., Jennifer Fox, William (BJ) Jones, Jr., Tomas Kiselak and Nimish Shah) voluntarily resigned from the Company’s board of directors","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1974640/000114036126035537/0001140361-26-035537-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"resigned"},{"label":"Role","value":"Director"}],"fact_type":"executive_change"},{"claim_id":"16ac30378d","claim":"Mark C. McKenna resigned as Director at Apogee Therapeutics, Inc..","evidence_excerpt":"all of the Company’s directors (Michael Henderson, M.D., Mark C. McKenna, Lisa Bollinger, M.D., Jennifer Fox, William (BJ) Jones, Jr., Tomas Kiselak and Nimish Shah) voluntarily resigned from the Company’s board of directors","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1974640/000114036126035537/0001140361-26-035537-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"resigned"},{"label":"Role","value":"Director"}],"fact_type":"executive_change"},{"claim_id":"1c7eadb464","claim":"Tomas Kiselak resigned as Director at Apogee Therapeutics, Inc..","evidence_excerpt":"all of the Company’s directors (Michael Henderson, M.D., Mark C. McKenna, Lisa Bollinger, M.D., Jennifer Fox, William (BJ) Jones, Jr., Tomas Kiselak and Nimish Shah) voluntarily resigned from the Company’s board of directors","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1974640/000114036126035537/0001140361-26-035537-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"resigned"},{"label":"Role","value":"Director"}],"fact_type":"executive_change"},{"claim_id":"5ef3140bb4","claim":"Jennifer Fox resigned as Director at Apogee Therapeutics, Inc..","evidence_excerpt":"all of the Company’s directors (Michael Henderson, M.D., Mark C. McKenna, Lisa Bollinger, M.D., Jennifer Fox, William (BJ) Jones, Jr., Tomas Kiselak and Nimish Shah) voluntarily resigned from the Company’s board of directors","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1974640/000114036126035537/0001140361-26-035537-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"resigned"},{"label":"Role","value":"Director"}],"fact_type":"executive_change"},{"claim_id":"b158dae44a","claim":"Michael Henderson resigned as Director at Apogee Therapeutics, Inc..","evidence_excerpt":"all of the Company’s directors (Michael Henderson, M.D., Mark C. McKenna, Lisa Bollinger, M.D., Jennifer Fox, William (BJ) Jones, Jr., Tomas Kiselak and Nimish Shah) voluntarily resigned from the Company’s board of directors","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1974640/000114036126035537/0001140361-26-035537-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"resigned"},{"label":"Role","value":"Director"}],"fact_type":"executive_change"},{"claim_id":"dac3135811","claim":"William (BJ) Jones resigned as Director at Apogee Therapeutics, Inc..","evidence_excerpt":"all of the Company’s directors (Michael Henderson, M.D., Mark C. McKenna, Lisa Bollinger, M.D., Jennifer Fox, William (BJ) Jones, Jr., Tomas Kiselak and Nimish Shah) voluntarily resigned from the Company’s board of directors","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1974640/000114036126035537/0001140361-26-035537-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"resigned"},{"label":"Role","value":"Director"}],"fact_type":"executive_change"},{"claim_id":"f353426f02","claim":"Nimish Shah resigned as Director at Apogee Therapeutics, Inc..","evidence_excerpt":"all of the Company’s directors (Michael Henderson, M.D., Mark C. McKenna, Lisa Bollinger, M.D., Jennifer Fox, William (BJ) Jones, Jr., Tomas Kiselak and Nimish Shah) voluntarily resigned from the Company’s board of directors","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1974640/000114036126035537/0001140361-26-035537-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"resigned"},{"label":"Role","value":"Director"}],"fact_type":"executive_change"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}